Advertisement

KHN

KHN’s ‘What the Health?’: Delta Blues

Covid is back with a vengeance, with some people clamoring for booster shots while others harden their resistance to getting vaccinated at all. Meanwhile, the Food and Drug Administration is pushing hard on drugmaker Pfizer’s request to upgrade the emergency authorization for its vaccine and give it final approval. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.

Read More

Pharmacies Face Extra Audit Burdens That Threaten Their Existence

Pharmacy benefit managers have curtailed in-person audits of pharmacy claims during the pandemic, switching to virtual audits done by computer. That has markedly increased the number of claims they can review — and the chances for payment denials — squeezing pharmacies and bringing in more cash for the benefit companies.

Read More

2+2=? Senate Uses Murky Math as It Shelves Drug Pricing Rule to Fund Infrastructure

The Medicare rule, designed by the Trump administration to take money away from drug industry brokers and provide refunds to patients, has not been implemented. But budget analysts say if it were, it would cost the government money. So senators are pushing the rule aside and claiming to save billions of dollars, which they want to use instead on new projects.

Read More

Why is the South the Epicenter of Anti-Abortion Fervor?

The Supreme Court, come autumn, will consider a Mississippi law that bans nearly all abortions after 15 weeks of pregnancy. That’s hardly the most restrictive abortion law passed in the South. How did anti-abortion views become concentrated in the South?

Read More

For latest news and updates
Email-id is invalid